COVID-19

Overview

At the end of December 2019, Chinese public health authorities reported several cases of acute respiratory syndrome in Wuhan City, Hubei province, China. Chinese scientists soon identified a novel coronavirus as the main causative agent. The disease is now referred to as coronavirus disease 2019 (COVID-19), and the causative virus is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is a new strain of coronavirus that has not been previously identified in humans.

The initial outbreak in Wuhan spread rapidly, affecting other parts of China. Cases were soon detected in several other countries. Outbreaks and clusters of the disease have since been observed in Asia, Europe, Australia, Africa and the Americas.

For a quick overview, please refer to the following pages:

 

The COVID-19 pandemic is rapidly evolving, and outbreak investigations are ongoing. ECDC is closely monitoring this outbreak, providing risk assessments, public health guidance, and advice on response activities to EU Member States and the EU Commission.

Latest updates

Publication

Rapid risk assessment: Coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – seventh update

Risk assessment -

Data

Download today’s data on the geographic distribution of COVID-19 cases worldwide

Table -

Publication

Communicable disease threats report, 22-28 March 2020, week 13

Publication -

Publication

Cloth masks and mask sterilisation as options in case of shortage of surgical masks and respirators

Technical report -

Publication

Disinfection of environments in healthcare and non-healthcare settings potentially contaminated with SARS-CoV-2

Technical report -

Situation update 30 March 2020, dataset collected 6:00-10:00 CET

715 660 cases
Worldwide
33 579 deaths
Whereof 23 461 deaths in the EU/EEA and the UK.
359 102 cases
in the EU/EEA and the UK.